Cytokinetics twitter
WebCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on March 31, 2024 it granted stock options to purchase an aggregate of 57,600 shares of common stock to 4 new … WebApr 10, 2024 · Zacks Equity Research. April 10, 2024, 9:23 AM · 3 min read. It has been a rough year so far for late-stage biopharmaceutical company, Cytokinetics, Incorporated …
Cytokinetics twitter
Did you know?
WebCytokinetics, Inc. is a publicly traded biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential … WebWebsite: www.cytokinetics.com Headquarters: South San Francisco, CA Size: 201 to 500 Employees Founded: 1997 Type: Company - Public (CYTK) Industry: Biotech & Pharmaceuticals Revenue: Unknown / Non-Applicable Competitors: Ionis Pharmaceuticals, MyoKardia, PTC Therapeutics Create Comparison
WebApr 12, 2024 · Cytokinetics had a negative return on equity of 1,401.63% and a negative net margin of 410.89%. The firm’s revenue for the quarter was down 96.5% compared to the same quarter last year. WebFeb 23, 2024 · SOUTH SAN FRANCISCO, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that SEQUOIA-HCM ( S afety, E fficacy, and Q uantitative U nderstanding of O bstruction I mpact of Aficamten in HCM ), a Phase 3 clinical trial of aficamten in patients with symptomatic obstructive …
WebFeb 27, 2024 · On Feb. 28, the FDA is set to decide on Cytokinetics ’ omecamtiv mecarbil (OM), a novel, selective cardiac myosin activator being evaluated for heart failure with reduced ejection fraction. The regulatory agency accepted the New Drug Application for OM in February 2024 and initially set a target action date of Nov. 30, 2024. WebOct 25, 2024 · Cytokinetics expects that it will end 2024 with more than $800 million in cash. This, despite the fact that it expects that its operating expenses for all of 2024 to end up being in the range of...
WebApr 10, 2024 · In 2024, Cytokinetics is celebrating its 25-year history of pioneering innovation in muscle biology and related pharmacology focused to diseases of muscle …
WebJun 24, 2024 · SOUTH SAN FRANCISCO, Calif., June 24, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the U.S. Food and Drug Administration (FDA) has informed the company... tspa allentownWebDec 13, 2024 · SOUTH SAN FRANCISCO, Calif., Dec. 13, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq: CYTK) today announced that Nasdaq has halted the trading of the Company’s common stock. phio circle self referralWebFeb 15, 2024 · Cytokinetics, Incorporated SOUTH SAN FRANCISCO, Calif., Feb. 15, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report fourth quarter... phio chemicalWebFeb 28, 2024 · The US FDA has issued a Complete Response Letter to Cytokinetics (NASDAQ:CYTK) for omecamtiv mecarbil for heart failure with reduced ejection fraction. Shares are down ~8% in post-market trading. t spa allentown pa reviewsWebFind the latest Cytokinetics, Incorporated (CYTK) stock quote, history, news and other vital information to help you with your stock trading and investing. t spa allentownWebApr 10, 2024 · For additional information about Cytokinetics, visit www.cytokinetics.com and follow us on Twitter, LinkedIn, Facebook and YouTube. Forward-Looking Statements. tsp abcWebSep 22, 2024 · The latest Tweets from Biomol Cytokines (@cytokines). You have the cells, we have the cytokines. Germany, Hamburg tsp abbreviation medical term